Raidium, a startup operating out of Paris and Silicon Valley, has introduced its AI-driven imaging platform, Raidium Read, at Moffitt Cancer Center in the US. This innovative tool has replaced the center’s previous radiomics software and is now being used in clinical trials and research. The company is anticipating FDA 510(k) clearance soon, aiming to expand its application further in medical imaging.
Back
